Objectives: To characterize the naturally occurring b-lactamase gene identified from a clinical isolate belonging to a novel enterobacterial species that is closely related to Rahnella spp. and Ewingella spp.
Introduction
The genera Rahnella and Ewingella are classified in the Enterobacteriaceae family. Few Rahnella species have been identified, and most of them have still not been named. Rahnella aquatilis is mainly found in water and soils, and may be an opportunistic pathogen in immunocompromised patients. 1 R. aquatilis harbours a b-lactamase gene encoding RAHN-1 sharing significant amino-acid identity and a similar b-lactam substrate profile with CTX-M-type b-lactamases. 2 The sole known species of the Ewingella genus is Ewingella americana, first described from clinical specimens in 1983, 3 whose pathogenic significance and ecological niche remain unknown. By testing a series of E. americana strains, Stock et al. 4 suggested that this species produced a naturally occurring AmpC-type b-lactamase, since it hydrolysed penicillins and cephalosporins, and its expression was inducible. We report here the characterization of a class A b-lactamase from a clinical isolate belonging to a novel enterobacterial species that is phylogenetically related to Rahnella spp. and Ewingella spp. and has a substrate profile including expandedspectrum cephalosporins.
Methods
Clinical isolate RUS was isolated from a bronchoalveolar lavage specimen from a patient with nosocomial pneumonia, hospitalized at the Region Clinical hospital of Smolensk, Russia, in September 2005. It was identified at the species level by rpoB gene sequencing as described. 6 Whole-cell DNA of strain RUS-1 was extracted as described previously. 4 It was partially digested with Sau3AI and ligated into the BamHI site of the pBK-CMV phagemid (Stratagene, Amsterdam, The Netherlands) as described previously. 7 The ligation products were electroporated into electrocompetent Escherichia coli DH10B (Bio-Rad, Ivry-sur-Seine, France). E. coli DH10B cells harbouring recombinant plasmids were selected on kanamycin (30 mg/L)-and ticarcillin (100 mg/ L)-containing Trypticase soy agar plates. Sequencing of the recombinant plasmid insert was performed as described previously. 7 The nucleotide and deduced protein sequences were analysed with software available over the internet at the National Center for Biotechnology Information web site (http://www.ncbi.nlm.nih.gov). Plasmid DNA extraction was performed as described previously. 4 Purification of b-lactamase SMO-1 was performed with a 2 L culture of E. coli DH10B harbouring recombinant plasmid pMF-1, as described previously. 7 Briefly, culture extracts were subjected to three purification steps using ion-exchange chromatography. First, a Q-Sepharose column equilibrated with 20 mM Tris-HCl buffer (pH 8.2) was used, and the enzyme was eluted with a linear NaCl gradient (0-1 M). Second, the fractions containing b-lactamase activity were dialysed against 20 mM diethanolamine buffer (pH 9.5) and loaded again on a Q-Sepharose column pre-equilibrated with the same buffer. The b-lactamase activity was eluted with a linear NaCl gradient (0-1 M). Finally, the fractions containing b-lactamase activity were dialysed against sodium phosphate buffer (pH 6.8) and loaded on an S-Sepharose column pre-equilibrated with the same buffer. The b-lactamase activity was eluted with a linear NaCl gradient (0-1 M). Purity of the fractions and relative molecular weight of the purified protein were estimated by SDS-PAGE analysis as described previously. 7 Kinetic measurements (k cat and K m ) of purified b-lactamase SMO-1 were performed using UV spectrophotometry as described previously. 7 Analytical isoelectric focusing (IEF) was performed as described previously. 7 The signal peptide cleavage site was determined in silico by using the SignalIP 4.1 Server available at http://www. cbs.dtu.dk/services/SignalP/.
Results
Molecular techniques revealed that strain RUS belonged to a novel species, likely being part of a novel genus. Based on rpoB gene sequencing, its closest relatives were R. aquatilis type strain CIP 78.65T (90.6% nucleotide identity) and E. americana type strain CIP 81.94T (93.3%) (data not shown). This clinical isolate was resistant to amoxicillin, ticarcillin, cefalotin and cefuroxime (Table 1) , remaining susceptible to the other b-lactams tested, including extended-spectrum cephalosporins.
Shotgun cloning gave a single E. coli DH10B recombinant clone, exhibiting a susceptibility pattern corresponding to the expression of an extended-spectrum b-lactamase (ESBL). It was resistant or had reduced susceptibility to amoxicillin, ticarcillin, piperacillin, cefotaxime, ceftazidime, cefepime and aztreonam ( Table 1 ). The susceptibility pattern of E. coli DH10B (pMF-1) mirrored that observed with E. coli strains expressing CTX-M-type b-lactamases, which do not confer resistance to ceftazidime in most cases. 8 The addition of clavulanic acid and tazobactam significantly lowered the MICs of cefotaxime, in accordance with the expression of a class A b-lactamase ( Table 1) .
The recombinant plasmid pMF-1 possessed a 2101 bp insert that was sequenced. An open reading frame (ORF) of 888 bp was identified. The G+ C content of this ORF was 50.6%, which lies within the G + C ratio of enterobacterial genes. Within the deduced protein of this ORF (295 amino acids), named SMO-1 (for SMOlensk, the city of strain isolation), elements characteristic of Ambler class A b-lactamases were identified (Figure 1 ). SMO-1 shared homologies with other class A b-lactamases, and the highest percentages of identity were found with the plasmidmediated ESBL SFO-1 (75%) or the chromosomally encoded FONA-6, which both originate from Serratia fonticola, 9,10 with the plasmid-mediated ESBL CTX-M-2 (74%) 11 and with the chromosomally encoded RAHN-1 b-lactamase from R. aquatilis.
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Upstream of the bla SMO-1 gene (224 bp), a 174 bp ORF was identified that encoded the first 58 amino acids of a putative LysR-type regulator protein, as found upstream of other chromosomeencoded class A b-lactamase genes, such as those intrinsic to Citrobacter diversus, Proteus vulgaris and S. fonticola.
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The presence of this regulatory gene might explain the induction of the b-lactamase production previously evidenced. 1 Plasmid DNA extraction failed to identify any plasmid in strain RUS, suggesting that the bla SMO-1 gene was chromosomally located. Furthermore, Southern hybridization performed with a bla SMO-1 -specific probe as described 15 gave a positive signal with the chromosomal band, further confirming the hypothesis of a chromosomal location.
IEF analysis performed from cultures of strain RUS and from E. coli DH10B (pMF-1) showed in both cases a single b-lactamase activity with a pI of 7.9. After purification from culture extracts of E. coli DH10B (pMF-1), the specific activity of b-lactamase SMO-1, measured with 100 mmol of cefalotin as the substrate at 308C in 100 mM sodium phosphate (pH 7.0), was 1 U/mg of protein, and its purification factor was 30-fold (one unit of enzyme activity being defined as the activity that hydrolysed 1 mmol of cefalotin per min). Protein purity was estimated to be .95% by SDS-PAGE Lartigue et al.
analysis (data not shown). The relative molecular mass of SMO-1 determined with the purified enzyme was 32 kDa (data not shown). The signal peptide cleavage site was identified as described previously. 16 N-terminal amino acid sequencing of the mature protein revealed that the cleavage site for the leader peptide is between amino acid positions 28 and 29 (K-AVQQK). Purified b-lactamase extracts were used for kinetic measurements performed at 308C in 100 mM sodium phosphate (pH 7.0). The k cat and K m values were determined by analysing b-lactam hydrolysis under initial-rate conditions with a UV spectrophotometer and by using the Eadie -Hofstee linearization of the Michaelis -Menten equation, as previously described. 16 The b-lactamase SMO-1 had strong activity against cefalotin and cefuroxime (Table S1 , available as Supplementary data at JAC Online). Significant hydrolytic activity was observed against cefotaxime, while a low level of activity was observed against ceftazidime. For this latter substrate, a high K m was obtained, thus confirming the very low affinity for that substrate (Table S1 , available as Supplementary data at JAC Online). SMO-1 hydrolysed imipenem at a very low level, as observed for some ESBLs. The efficacy of serine b-lactamase inhibitors was evaluated by determination of 50% inhibitory concentrations, showing that SMO-1 was well inhibited by clavulanic acid (0.05 mM), tazobactam (0.01 mM) and sulbactam (0.15 mM).
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These results showed that b-lactamase SMO-1 is an Ambler class A ESBL 17 belonging to the group 2be according to the Bush -Jacoby-Medeiros b-lactamase classification. 18 
Discussion
We characterized here SMO-1, which is a clavulanic acid-inhibited Ambler class A ESBL including broad-spectrum cephalosporins except ceftazidime in its hydrolysis profile. This finding further ESBL SMO-1 from a new enterobacterial species 1735 JAC highlights that enterobacterial species may be natural producers of ESBLs, as previously shown with Kluyvera spp. SMO-1 exhibits amino acid residues at key positions that may explain its extended spectrum of hydrolysis. In particular, the serine residue at position Ambler 237 may contribute to this extended substrate profile, as reported for the b-lactamase of S. fonticola. 9 Interestingly, most of the chromosomally encoded class A b-lactamases from members of the family Enterobacteriaceae (S. fonticola, P. vulgaris, Citrobacter koseri, Kluyvera ascorbata, Kluyvera cryocrescens and Kluyvera georgiana) have the same substrate profile, which includes amino-and ureidopenicillins, cefalotin, cefuroxime, cefotaxime and ceftriaxone, but not ceftazidime. 8 They may be the source of acquired resistance, as extensively described with the different types of plasmid-encoded CTX-Ms, corresponding to the chromosomally encoded b-lactamases of Kluyvera spp., respectively. Therefore, this new species may be added to the list of progenitors of ESBL genes that can be mobilized from their chromosomal location to plasmid backbones, allowing their inter-strain or inter-species spread.
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